Press release
Worldwide Insomnia Industry is Expected to Grow CAGR 4.5 % during Forecast Period of 2023
Insomnia is a common sleep disorder. It was estimated that approximately 30 -35% of global population is suffering from this disorder. Disturbance in sleep frequently awaking or difficulty in returning to sleep after awaking are the major complication in insomnia. Treatment of insomnia is given on the basis of the condition or severity of disease. Low dose of antidepressant and no benzodiazepine are normally administer. Increasing social stress, more workload and thinking about future are the major reasons for increasing symptoms like insomnia. Women are more likely to suffer from this disorder. Global insomnia market is growing at a steady rate during past few years and is expected to grow at a CAGR of 4.5% in coming future. Insomnia drug have found its application in treatment of other diseases like Alzheimer’s and Parkinson disease which has help to boost the market of insomnia. The insomnia market is hampered due to patient expiry of Sunovion in 2014 which was a top selling insomnia drug. However the new launches of product like Belsomra by Merck & Co. Inc and E-2006 by Eisai Co. will help to increase the market in coming future. The major driving factor for the insomnia market are increasing number of mental disorder, increase in patient suffering from Alzheimer’s and Parkinson’s disease, increasing workload and stress. Lack of awareness and education, and challenge to provide a cheap drugs compare with other brand can be responsible hampering the market growth.
Get a sample copy of this report at https://www.marketresearchfuture.com/sample_request/545 .
Global Insomnia market is segmented into four geographies- North America, Europe, Asia Pacific and Middle East and Africa. Due to increasing number mental and psychological disorder insomnia market has got fuel for the development. Global insomnia market is dominated by North America. US accounts the biggest market in the world which is followed by Japan. It was estimated the insomnia market in Japan will reach to 400.4 million till 2023.
Global Insomnia Market has been segmented on the basis of types of therapy which comprises Pharmacological therapy which is further sub segmented into benzodiazepines, non-benzodiazepines, melatonin receptor agonists and other. Non Pharmacological therapy which is sub segmented into Relaxation therapy, Cognitive Behavioral Therapy, Sleep Hygiene Education, Stimulus Control, Paradoxical Intention and Other. By drug formulation they are segmented as Capsules, Tablet and others. On the basis of condition of diseases they are poor quality of sleep, sleep maintenance and other.
Majority of market is dominated by
• Eisai, Co. (Japan)
• Pfizer, Inc. (US)
• Merck & Co Inc (US)
• Sanofi (France)
• Takeda Pharmaceutical Company (Japan)
• Meda Consumer Healthcare Inc (US)
• Pernix Therapeutics (US)
• Purdue Pharma L.P. (US)
• Consumer Healthcare Inc. (Canada)
• Dainippon Sumitomo (Japan)
• ECR Pharmaceuticals (US)
• Flynn Pharma (UK)
• Johnson & Johnson (US)
• Astellas (UK)
• Biocodex S A (France)
• Neurim (Switzerland)
• SkyePharma (UK),
• Vanda Pharmaceuticals Inc. (US)
Browse Complete Report at https://www.marketresearchfuture.com/reports/insomnia-market-545 .
Study Objectives Global Insomnia Market Research Report
• To provide the Detail Overview of parent market.
• To provide In-depth market segmentation and sub segmentations.
• To provide insights about factors affecting the market growth
• To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide Competitive landscape and key players in the market.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia Pacific and Middle East and Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global insomnia market.
Intended Audience
• Manufacturing and packaging industries.
• Insomnia devices and drug manufacturers
• Insomnia devices and drug suppliers
• Biotechnology Companies
• Bio-Pharmaceutical Companies
• Research and Development (R&D) Companies
• Government Research Laboratories
• Medical Research Institutes
Get a discount at https://www.marketresearchfuture.com/check-discount/545 .
TABLE OF CONTENTS
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL INSOMNIA MARKET, BY TYPES OF THERAPY
5.1 PHARMACOLOGICAL THERAPY
5.1.1 BENZODIAZEPINES
5.1.2 NON-BENZODIAZEPINES
5.1.3 MELATONIN RECEPTOR AGONISTS
5.1.4 OTHER
5.2 NON PHARMACOLOGICAL THERAPY
5.2.1 RELAXATION THERAPY
5.2.2 COGNITIVE BEHAVIORAL THERAPY
5.2.3 SLEEP HYGIENE EDUCATION
5.2.4 STIMULUS CONTRO
5.2.5 PARADOXICAL INTENTION
5.2.6 OTHER
6. GLOBAL INSOMNIA MARKET, BY DRUG FORMULATION
6.1 CAPSULES
6.2 TABLET
6.3 OTHERS.
7. GLOBAL INSOMNIA MARKET, BY DISEASES CONDITION
7.1 POOR QUALITY OF SLEEP
7.2 SLEEP MAINTENANCE
7.3 OTHER.
8. GLOBAL INSOMNIA MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 WESTERN EUROPE
8.3.1.1 GERMANY
8.3.1.2 FRANCE
8.3.1.3 ITALY
8.3.1.3 SPAIN
8.3.1.5 UK
8.3.1.6 REST OF WESTERN EUROPE
8.3.2 EASTERN EUROPE
8.4 ASIA
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 AUSTRALIA
8.4.5 REPUBLIC OF KOREA
8.5 REST OF ASIA-PACIFIC
8.6 MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
8.1.1 STRATEGIC PARTNERSHIP
9.1.2 MERGER & ACQUISITION
10 COMPANY PROFILE
10.1 EISAI, CO.
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 MERCK & CO INC
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 SANOFI
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 STRATEGY
10.3.5 KEY DEVELOPMENT
10.4 TAKEDA PHARMACEUTICAL COMPANY
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 PFIZER, INC.
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 OTHERS
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Akash Anand
P: +1 646 845 9312
W: www.marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Worldwide Insomnia Industry is Expected to Grow CAGR 4.5 % during Forecast Period of 2023 here
News-ID: 664799 • Views: …
More Releases from Market Research Future
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
